Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ENROLLING BY INVITATION
NCT06604130
NA

Plasma Exosome RNA to Diagnose Prostate Cancer

Sponsor: Xijing Hospital

View on ClinicalTrials.gov

Summary

The aim of the present study is to investigate a RNA combination to diagnose prostate cancer.

Official title: Plasma Exosome RNA Combination for Diagnosing Prostate Cancer: a Prospective, Multicenter Diagnostic Trial

Key Details

Gender

MALE

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

1600

Start Date

2021-03-12

Completion Date

2025-12-31

Last Updated

2025-11-28

Healthy Volunteers

Yes

Conditions

Interventions

DIAGNOSTIC_TEST

Prostate cancer screening decision

The subjects would receive serum PSA test.

Locations (9)

The First Hospital of Lanzhou University

Lanzhou, Gansu, China

General Hospital of Ningxia Medical University

Yinchuan, Ningxia, China

Qinghai University Affiliated Hospital

Xining, Qinghai, China

Weinan Central Hospital

Weinan, Shaanxi, China

Shaanxi Provincial People's Hospital

Xi'an, Shaanxi, China

Xijing 986 Hospital

Xi'an, Shaanxi, China

Xijing Hospital

Xi'an, Shaanxi, China

The Second Affiliated Hospital of Shaanxi University of Chinese Medicine

Xianyang, Shaanxi, China

Affiliated Hospital of Yan'an University,

Yan’an, Shaanxi, China